These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 30815833

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review.
    Ahmed AI, Abebe AT, Han Y, Alnabelsi T, Agrawal T, Kassi M, Aljizeeri A, Taylor A, Tleyjeh IM, Al-Mallah MH.
    J Nucl Cardiol; 2021 Aug; 28(4):1545-1552. PubMed ID: 34228337
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
    Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.
    J Am Coll Cardiol; 2014 Feb 04; 63(4):329-36. PubMed ID: 24140661
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on 18F-FDG PET Scans for Suspected Cardiac Sarcoidosis.
    Sperry BW, Tamarappoo BK, Oldan JD, Javed O, Culver DA, Brunken R, Cerqueira MD, Hachamovitch R.
    JACC Cardiovasc Imaging; 2018 Feb 04; 11(2 Pt 2):336-345. PubMed ID: 28823747
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
    Ahmadian A, Pawar S, Govender P, Berman J, Ruberg FL, Miller EJ.
    J Nucl Cardiol; 2017 Apr 04; 24(2):413-424. PubMed ID: 27457527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.
    Flores RJ, Flaherty KR, Jin Z, Bokhari S.
    J Nucl Cardiol; 2020 Dec 04; 27(6):2003-2010. PubMed ID: 30421379
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG-PET in Finnish patients with clinical suspicion of cardiac sarcoidosis: Female sex and history of atrioventricular block increase the prevalence of positive PET findings.
    Tuominen H, Haarala A, Tikkakoski A, Korkola P, Kähönen M, Nikus K, Sipilä K.
    J Nucl Cardiol; 2019 Apr 04; 26(2):394-400. PubMed ID: 28585031
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
    Tahara N, Tahara A, Nitta Y, Kodama N, Mizoguchi M, Kaida H, Baba K, Ishibashi M, Hayabuchi N, Narula J, Imaizumi T.
    JACC Cardiovasc Imaging; 2010 Dec 04; 3(12):1219-28. PubMed ID: 21163450
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.